Shulph Ink
New Targeting in The Reversal of Resistant Glioblastomas
New Targeting in The Reversal of Resistant Glioblastomas
- Condition: Brand new
- UK Delivery times: Usually arrives within 2 - 3 working days
- UK Shipping: Fee starts at £2.39. Subject to product weight & dimension
Couldn't load pickup availability
Excellent- More about New Targeting in The Reversal of Resistant Glioblastomas
New Targeting in The Reversal of Resistant Glioblastomas discusses alternative treatment strategies that target the tumor microenvironment, metabolic pathways, and interaction of cytokines in tumor cells, helping to rethink treatment strategies to fight glioblastomas.
Format: Hardback
Length: 202 pages
Publication date: 10 March 2021
Publisher: Elsevier Science Publishing Co Inc
The Reversal of Resistant Glioblastomas delves into innovative treatment approaches that go beyond targeting tumor cells alone, encompassing the tumor microenvironment, metabolic pathways, and intricate interactions between cytokines within glioblastoma cells. Unfortunately, the current treatment regimen for primary and recurrent glioblastomas is failing, largely due to the neglect of the influence of bone marrow-derived cells on the development of resistance to clinically practiced therapies. This groundbreaking book serves as a catalyst for readers to reevaluate their treatment strategies, empowering them to effectively combat glioblastomas. It is an invaluable resource for cancer researchers, clinicians, graduate students, and all individuals engaged in the biomedical field.
The Reversal of Resistant Glioblastomas explores cutting-edge treatment modalities that transcend the confines of solely targeting tumor cells, encompassing the tumor microenvironment, metabolic pathways, and intricate cytokine interactions within glioblastoma cells. Regrettably, the current treatment approach for primary and recurrent glioblastomas is failing, primarily due to the disregard for the role of bone marrow-derived cells in the emergence of resistance to clinically employed therapies. This groundbreaking book acts as a transformative force, prompting readers to reassess their treatment approaches and empowering them to successfully combat glioblastomas. It is an indispensable resource for cancer researchers, clinicians, graduate students, and all individuals engaged in the biomedical realm.
Weight: 580g
Dimension: 198 x 244 x 19 (mm)
ISBN-13: 9780128225271
This item can be found in:
UK and International shipping information
UK and International shipping information
UK Delivery and returns information:
- Delivery within 2 - 3 days when ordering in the UK.
- Shipping fee for UK customers from £2.39. Fully tracked shipping service available.
- Returns policy: Return within 30 days of receipt for full refund.
International deliveries:
Shulph Ink now ships to Australia, Canada, France, Ireland, Italy, Germany, Spain, Netherlands, New Zealand and the United States of America.
- Delivery times: within 5 - 20 business days when ordering to France, Germany, Ireland, Spain, Canada and the United States. Up to 30 business days for Australia and New Zealand.
- Shipping fee: charges vary for overseas orders. Only tracked services are available for international orders.
- Customs charges: If ordering to addresses outside the United Kingdom, you may or may not incur additional customs and duties fees during local delivery.
